RecruitingNCT06580860

Psychiatric Multi-omics and Neuroimaging Project

Psychiatric Multi-omics and Neuroimaging Project Database


Sponsor

mingjun Zhong

Enrollment

1,899 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.


Eligibility

Min Age: 13 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This research project collects brain scans, genetic samples, and other biological data from young people with psychiatric conditions — such as depression, psychosis, or bipolar disorder — to better understand the biology of these illnesses. The goal is to find markers that can help diagnose and treat mental health conditions more precisely. **You may be eligible if...** - You are between 13 and 35 years old - You have a psychiatric condition that has been present for less than 24 months - You have never taken psychiatric medication, or only taken it for less than 2 weeks - You have no contraindications to MRI scans **You may NOT be eligible if...** - You have metal implants or other conditions that make MRI unsafe - You have a severe intellectual disability - You have significant medical conditions unrelated to the psychiatric illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAntipsychotic drugs, antidepressants, mood stabilizers, and sleep aids

Patients with mental disorders should take the appropriate medicine as prescribed by the doctor,and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.


Locations(1)

The Second Xiangya hospital of central south univerity

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06580860


Related Trials